Important Takeaways:

• Johnson & Johnson plans to spend over $55 billion to build four plants in the U.S., it said on Friday, as a threat of drug import duties from the Trump administration forces companies to expand their manufacturing operations domestically.
• The new plants will be built over the next four years, including in Wilson, North Carolina, where the pharmaceutical giant officially broke ground on Friday. The drug and device maker said the investment represents a 25% increase compared to the last four years.
• Trump, who campaigned on a promise to boost domestic manufacturing, has been piling pressure on drugmakers since taking office to move medicine production to the United States.
• J&J’s site in Wilson, where it plans to invest more than $2 billion, is expected to create 5,000 jobs during construction, and more than 500 positions across the state. The site will focus on producing medicines used for treating cancer, immune-mediated and neurological diseases, it said.

Read the original article by clicking here.